CERNER CORP's ticker is CERN and the CUSIP is 156782104. A total of 739 filers reported holding CERNER CORP in Q4 2017. The put-call ratio across all filers is 1.06 and the average weighting 0.3%.
About CERNER CORP
Cerner Corp is a leading healthcare technology company that provides innovative solutions to healthcare providers worldwide. The company was founded in 1979 and is headquartered in Kansas City, Missouri. Cerner's mission is to improve the quality of healthcare by providing advanced technology solutions that enable healthcare providers to deliver better patient care.
Cerner's products and services include electronic health records (EHRs), revenue cycle management, population health management, and clinical decision support systems. The company's EHRs are used by healthcare providers to manage patient information, including medical history, medications, and test results. Cerner's revenue cycle management solutions help healthcare providers manage their billing and payment processes, while its population health management solutions enable providers to manage the health of entire populations of patients.
Cerner has a strong track record of innovation and has been recognized for its contributions to the healthcare industry. The company has received numerous awards for its products and services, including the Best in KLAS award for its EHRs and revenue cycle management solutions.
Cerner's leadership team is comprised of experienced healthcare and technology professionals who are committed to improving the quality of healthcare. The company's CEO, Brent Shafer, has more than 30 years of experience in the healthcare industry and has been instrumental in driving Cerner's growth and success.
In conclusion, Cerner Corp is a leading healthcare technology company that is committed to improving the quality of healthcare. With its innovative products and services, experienced leadership team, and strong track record of success, Cerner is well-positioned to continue driving innovation in the healthcare industry for years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $2,746,000 | -72.5% | 29,346 | -72.7% | 0.01% | -73.0% |
| Q4 2021 | $9,975,000 | +4.5% | 107,402 | -20.6% | 0.04% | -2.6% |
| Q3 2021 | $9,541,000 | -9.4% | 135,293 | +0.5% | 0.04% | -11.6% |
| Q2 2021 | $10,526,000 | +9.3% | 134,676 | +0.6% | 0.04% | +4.9% |
| Q1 2021 | $9,627,000 | +10.1% | 133,935 | +20.3% | 0.04% | 0.0% |
| Q4 2020 | $8,741,000 | +11.8% | 111,380 | +3.0% | 0.04% | +2.5% |
| Q3 2020 | $7,817,000 | +7.4% | 108,139 | +1.8% | 0.04% | -7.0% |
| Q2 2020 | $7,279,000 | +149.6% | 106,180 | +129.3% | 0.04% | +104.8% |
| Q1 2020 | $2,916,000 | -14.7% | 46,299 | -0.6% | 0.02% | +10.5% |
| Q4 2019 | $3,417,000 | +10.3% | 46,558 | +2.5% | 0.02% | +5.6% |
| Q3 2019 | $3,098,000 | -7.9% | 45,443 | -1.0% | 0.02% | -10.0% |
| Q2 2019 | $3,364,000 | +30.8% | 45,899 | +2.1% | 0.02% | +25.0% |
| Q1 2019 | $2,571,000 | +6.8% | 44,938 | -2.2% | 0.02% | -11.1% |
| Q4 2018 | $2,408,000 | -16.8% | 45,928 | +2.2% | 0.02% | 0.0% |
| Q3 2018 | $2,894,000 | +9.6% | 44,936 | +1.8% | 0.02% | +12.5% |
| Q2 2018 | $2,640,000 | +8.4% | 44,151 | +5.1% | 0.02% | 0.0% |
| Q1 2018 | $2,436,000 | -14.0% | 42,002 | -0.1% | 0.02% | -5.9% |
| Q4 2017 | $2,834,000 | +1.8% | 42,058 | +7.8% | 0.02% | 0.0% |
| Q3 2017 | $2,783,000 | +7.8% | 39,028 | +0.5% | 0.02% | -5.6% |
| Q2 2017 | $2,582,000 | +16.5% | 38,844 | +3.1% | 0.02% | +20.0% |
| Q1 2017 | $2,217,000 | +26.8% | 37,665 | +2.0% | 0.02% | +15.4% |
| Q4 2016 | $1,749,000 | -22.2% | 36,931 | +1.4% | 0.01% | -23.5% |
| Q3 2016 | $2,249,000 | -2.2% | 36,418 | -7.2% | 0.02% | 0.0% |
| Q2 2016 | $2,299,000 | +10.6% | 39,228 | -0.0% | 0.02% | +6.2% |
| Q1 2016 | $2,078,000 | -10.2% | 39,229 | +2.0% | 0.02% | -15.8% |
| Q4 2015 | $2,314,000 | -0.4% | 38,463 | -0.8% | 0.02% | 0.0% |
| Q3 2015 | $2,324,000 | -12.3% | 38,755 | +0.9% | 0.02% | +5.6% |
| Q2 2015 | $2,651,000 | -1.0% | 38,393 | +5.0% | 0.02% | -5.3% |
| Q1 2015 | $2,678,000 | +23.6% | 36,554 | +9.1% | 0.02% | +35.7% |
| Q4 2014 | $2,166,000 | -12.7% | 33,496 | -19.5% | 0.01% | -6.7% |
| Q3 2014 | $2,480,000 | -61.2% | 41,627 | -66.4% | 0.02% | -58.3% |
| Q2 2014 | $6,390,000 | -11.1% | 123,884 | -3.0% | 0.04% | -14.3% |
| Q1 2014 | $7,185,000 | -3.9% | 127,728 | -4.8% | 0.04% | -8.7% |
| Q4 2013 | $7,480,000 | +2.1% | 134,194 | -3.7% | 0.05% | -2.1% |
| Q3 2013 | $7,324,000 | +0.4% | 139,376 | +83.6% | 0.05% | -6.0% |
| Q2 2013 | $7,294,000 | – | 75,904 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Veritas Investment Management LLP | 1,104,280 | $80,861,000 | 7.24% |
| Starboard Value LP | 3,000,000 | $219,900,000 | 6.69% |
| Veritas Investment Management (UK) Ltd | 272,989 | $20,010,000 | 5.68% |
| PRENTISS SMITH & CO INC | 103,500 | $7,587,000 | 4.95% |
| LGT CAPITAL PARTNERS LTD. | 855,290 | $62,693,000 | 4.61% |
| CIM, LLC | 139,925 | $10,257,000 | 3.54% |
| Freshford Capital Management, LLC | 284,989 | $20,889,000 | 3.52% |
| OBERMEYER WOOD INVESTMENT COUNSEL, LLLP | 472,232 | $34,615,000 | 3.11% |
| St. James Investment Company, LLC | 411,062 | $30,131,000 | 2.90% |
| PARNASSUS INVESTMENTS, LLC | 10,200,957 | $747,730,000 | 2.83% |